Covered recipient · General Payments record
HARSHITHA MANNAM
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$769.86
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.04 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $55.01 | 3 |
| ABBVIE INC. | $49.06 | 3 |
| Amgen Inc. | $34.69 | 2 |
| Regeneron Healthcare Solutions, Inc. | $34.24 | 2 |
| PFIZER INC. | $18.49 | 1 |
| Galderma Laboratories, L.P. | $17.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.73 | 1 |
| Incyte Corporation | $14.41 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.64 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104959114 | CMS |
| ABBVIE INC. | $15.85 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104959116 | CMS |
| ABBVIE INC. | $14.57 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104959118 | CMS |
| Amgen Inc. | $16.24 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117318242 | CMS |
| Amgen Inc. | $18.45 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117318244 | CMS |
| Galderma Laboratories, L.P. | $17.41 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145314603 | CMS |
| Incyte Corporation | $14.41 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141202687 | CMS |
| Lilly USA, LLC | $19.05 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014739 | CMS |
| Lilly USA, LLC | $17.27 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135021504 | CMS |
| Lilly USA, LLC | $18.69 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135014539 | CMS |
| Novartis Pharmaceuticals Corporation | $14.73 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087131524 | CMS |
| PFIZER INC. | $18.49 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131603568 | CMS |
| Regeneron Healthcare Solutions, Inc. | $16.99 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114107519 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.25 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114107521 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.00 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152152801 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.